Tower Research Capital LLC (TRC) - NAVIDEA BIOPHARMACEUTICALS I ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$804
+11.2%
8,937
+13.7%
0.00%
Q2 2023$723
+36050.0%
7,857
-0.7%
0.00%
Q1 2023$20.0%7,911
+0.1%
0.00%
Q4 2022$2
-99.9%
7,900
-6.2%
0.00%
Q3 2022$2,0000.0%8,424
+246.8%
0.00%
Q2 2022$2,000
-33.3%
2,429
-39.9%
0.00%
Q1 2022$3,000
-50.0%
4,042
-27.9%
0.00%
Q4 2021$6,000
-45.5%
5,608
-12.3%
0.00%
Q3 2021$11,000
+450.0%
6,394
+716.6%
0.00%
Q1 2021$2,000
-50.0%
783
-40.5%
0.00%
Q3 2020$4,000
-71.4%
1,317
-63.0%
0.00%
-100.0%
Q2 2020$14,0003,5580.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2023
NameSharesValueWeighting ↓
Allred Capital Management, LLC 466,688$41,8620.02%
Warberg Asset Management LLC 194,997$17,4910.00%
Virtu Financial LLC 333,069$300.00%
UBS Group AG 149,612$13,4660.00%
NewEdge Advisors, LLC 412$360.00%
Parallel Advisors, LLC 350$310.00%
BANK OF AMERICA CORP /DE/ 1,604$1430.00%
WELLS FARGO & COMPANY/MN 5,632$5040.00%
NORTHERN TRUST CORP 39,414$3,5350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders